MEDIROM Healthcare Technologies Inc. Announces May 2022 Key Performance Indicators (KPIs)
21 Giugno 2022 - 2:55PM
MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic
healthcare company based in Japan (the “Company”), today announced
its major Key Performance Indicators, or KPIs, updated for the
month of May 2022. Data is provided for all salons for which
comparative financial and customer data is available and excludes
certain salons where such information is not available.
The following monthly KPIs provide insight into
the business fundamentals and progress of the Company, updated for
the month of May 2022.
- The number of salons was 308 in May
2022, down from 313 in the year-ago period.
- Total customers served increased to
77,291 in May 2022 from 66,604 in the year-ago period. The increase
is primarily attributed to the increase in the number of salons
with available financial and customer data, and the recovery from
the impact of COVID-19.
- Sales per customer increased to
JPY6,461 in May 2022, up from JPY6,370 in May 2021. The increase is
attributed to the upselling of value-added optional services.
- Our repeat ratio, a measure of
repeat customers, decreased to 79.6% in May 2022 from 80.6% in the
year-ago period.
- Our operation ratio increased to
50.1% in May 2022 from 48.7% in the year-ago period. The increase
is primarily attributed to the increase in the total customers
served.
- The total number of salons with
data increased to 232 in March 2022 from 212 in March 2021. The
increase is attributed to the completion of the replacement of the
customer management system in certain salons. The number of salons
with data decreases when we close salons with data available and
increases as we open salons with such data.
|
Number of Salons(*1) |
Number of Salons with Data(*2) |
Total Customers Served(*3) |
Sales per Customer(*4) |
Repeat Ratio(*5) |
Operation Ratio(*6) |
May-21 |
313 |
212 |
66,604 |
JPY 6,370 |
80.6% |
48.7% |
June-21 |
313 |
219 |
68,069 |
JPY 6,350 |
81.2% |
48.6% |
July-21 |
314 |
220 |
70,912 |
JPY 6,498 |
81.0% |
48.1% |
August-21 |
315 |
221 |
66,323 |
JPY 6,592 |
81.3% |
46.5% |
September-21 |
316 |
221 |
65,130 |
JPY 6,428 |
82.0% |
46.7% |
October-21 |
316 |
221 |
68,608 |
JPY 6,486 |
83.3% |
48.9% |
November-21 |
316 |
221 |
65,569 |
JPY 6,466 |
81.9% |
47.7% |
December-21 |
312 |
221 |
71,173 |
JPY 6,634 |
81.7% |
50.5% |
January-22 |
312 |
221 |
62,747 |
JPY 6,570 |
82.4% |
48.2% |
February-22 |
310 |
219 |
54,443 |
JPY 6,662 |
83.8% |
46.4% |
March-22 |
310 |
217 |
61,417 |
JPY 6,595 |
82.4% |
46.5% |
April-22 |
309 |
232 |
69,986 |
JPY 6,616 |
82.0% |
48.3% |
May-22 |
308 |
232 |
77,291 |
JPY 6,461 |
79.6% |
50.1% |
(*1) Number of Salons: Includes our
directly-operated salons, and franchisees’ salons.(*2) Number of
Salons with Data: The number of salons for which comparable
financial and customer data is available.(*3) Total Customers
Served: The number of customers served at salons for which
comparative financial and customer data is available.(*4) Sales Per
Customer: The ratio of total salon sales to number of treated
customers at all salons for which comparable financial and customer
data is available.(*5) Repeat Ratio: The ratio of repeat customer
visits to total customer visits in the applicable month for all
salons for which comparable financial and customer data is
available.(*6) Operation Ratio: The ratio of therapists’ in-service
time to total therapists’ working hours (including stand-by time)
for the applicable month for all salons for which comparable
financial and customer data is available.
*Since July 2021, the salon operation business has
been managed by Wing Inc., which is a wholly-owned subsidiary of
the Company.
About MEDIROM Healthcare Technologies
Inc.MEDIROM a holistic healthcare company, operates 308
(as of May 31, 2022) relaxation salons across Japan, Re.Ra.Ku®,
being its leading brand, and provides healthcare services. In 2015,
MEDIROM entered the health tech business, and launched new
healthcare programs using on-demand training app called “Lav®”,
which is developed by the company. MEDIROM also entered the device
business in 2020 and is developing a smart tracker “MOTHER
Bracelet” (formerly known as “MOTHER Tracker®”). MEDIROM hopes that
its diverse health related services and products offering will help
it collect and manage healthcare data from users and customers and
enable it to become a leader in big data in the healthcare
industry. For more information, visit https://medirom.co.jp/en
Forward-Looking
StatementsCertain statements in this press release are
forward-looking statements for purposes of the safe harbor
provisions under the U.S. Private Securities Litigation Reform Act
of 1995. Forward-looking statements may include estimates or
expectations about the Company’s possible or assumed operational
results, financial condition, business strategies and plans, market
opportunities, competitive position, industry environment, and
potential growth opportunities. In some cases, forward-looking
statements can be identified by terms such as “may,” “will,”
“should,” “design,” “target,” “aim,” “hope,” “expect,” “could,”
“intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,”
“predict,” “project,” “potential,” “goal,” or other words that
convey the uncertainty of future events or outcomes. These
statements relate to future events or to the Company’s future
financial performance, and involve known and unknown risks,
uncertainties and other factors that may cause the Company’s actual
results, levels of activity, performance, or achievements to be
materially different from any future results, levels of activity,
performance or achievements expressed or implied by these
forward-looking statements. You should not place undue reliance on
forward-looking statements since they involve known and unknown
risks, uncertainties and other factors which are, in some cases,
beyond the Company’s control and which could, and likely will,
materially affect actual results, levels of activity, performance
or achievements. Any forward-looking statement reflects the
Company’s current views with respect to future events and is
subject to these and other risks, uncertainties and assumptions
relating to the Company’s operations, results of operations, growth
strategy and liquidity. The Company assumes no obligation to
publicly update or revise these forward-looking statements for any
reason, or to update the reasons actual results could differ
materially from those anticipated in these forward-looking
statements, even if new information becomes available in the
future.
Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/371210b7-87cd-41c8-bd83-6bc362535143
https://www.globenewswire.com/NewsRoom/AttachmentNg/5e05c8a5-a088-40f7-a5f2-15247bf1cf5c
https://www.globenewswire.com/NewsRoom/AttachmentNg/b4b4f57f-e810-41ec-9086-ca589aa8ea5d
https://www.globenewswire.com/NewsRoom/AttachmentNg/11360dfe-8fbd-4fbf-8b37-7c4b9aacf7fa
https://www.globenewswire.com/NewsRoom/AttachmentNg/22086c67-0c4e-4845-9fa9-6c1fa4a00566
Contacts
Investor Relations Team
ir@medirom.co.jp
Or
U.S. Investor Contact
Robert Blum, Joe Diaz, Joe Dorame
Lytham Partners, LLC
602-889-9700
MRM@lythampartners.com
Grafico Azioni MEDIROM Healthcare Techn... (NASDAQ:MRM)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni MEDIROM Healthcare Techn... (NASDAQ:MRM)
Storico
Da Giu 2023 a Giu 2024